Renata O. Smith
Clinical Assistant Professor, Pharmacy Practice
Contact
Address:
833 S.Wood St, M/C 886, Chicago, IL
Office Phone:
Email:
Related Sites:
About
Research Interests:
HIV/HCV/PrEP/Gender affirming Care/Transitions of care
Teaching and Supervision
Undergrad Resrch Pharm Pract (PMPR 380), 8/26/2024 – 12/6/2024
ISTP Didactics, 4/11/2023 – Present
Special Topics (PHAR 508), 8/23/2021 – Present
Special Topics (PHAR 508), 8/23/2021 – Present
Special Topics (PHAR 508), 8/23/2021 – Present
PHAR 508 Special Topics, 8/23/2021 – Present
PDAT 8 Special Topics (PHAR 508), 8/23/2021 – Present
Undergrad Resrch Pharm Pract (PMPR 380), 1/11/2021 – 4/30/2021
Immunology/Respiratory (PHAR 504), 8/24/2020 – Present
Selected Grants
The Chicago Rapid Start Hepatitis C Treatment Program – Combining Rapid Diagnostics, Mobile MOUD, and Hepatitis C Treatment, Gilead Sciences., 6/15/2025 - 5/30/2026, Obligated Amount: $17000; No Anticipated Amount Set
The Chicago Rapid Start Hepatitis C Treatment Program – Combining Rapid Diagnostics, Mobile MOUD, and Hepatitis C Treatment, Gilead Sciences., 5/30/2025 - Present, Obligated Amount: $17000; No Anticipated Amount Set
CDPH Linkage to Care and Treatment, City of Chicago Department of Public Health., 4/30/2024 - Present, Obligated Amount: $250000; No Anticipated Amount Set
21S Design for the margins, Health Resources and Services Administration., 1/2/2023 - 3/31/2025, Obligated Amount: $82755; No Anticipated Amount Set
Using Innovative Interventions to Improve Health Outcomes Among People with HIV, he Fenway Institute and AIDS United., 6/1/2022 - Present, No Obligated Amount Set; No Anticipated Amount Set
USTART, HRSA., 7/6/2020 - 12/31/2024, No Obligated Amount Set; No Anticipated Amount Set
CRRT Service Contract, Chicago Department of Public Health., 7/1/2020 - 3/31/2022, Obligated Amount: $1000000; No Anticipated Amount Set
Merck Investigator Initiated Studies Program, Merck & Co., Inc.., 10/2019 - 12/31/2024, Obligated Amount: $125941.25; No Anticipated Amount Set
Merck Investigator Initiated Studies Program, Merck & Co., Inc.., 10/2019 - 12/31/2024, Obligated Amount: $125941.25; No Anticipated Amount Set
Selected Publications
Knodle, Ryan D, Messmer, Sarah E, Murphy, Albert L, Smith, Renata O, Huyck, Michael, Cotler, Karen, Jimenez, Antonio D, Mayer, Stockton M. (2025). Comprehensive Care for People Who Use Drugs: Combining Infectious Diseases Services, Harm Reduction, and Primary Care. Open Forum Infectious Diseases, 12, (5), ofaf226. doi:10.1093/ofid/ofaf226.
Guzman, Miriam, Smith, Renata, Mayer, Stockton, Messmer, Sarah, Huyck, Michael, Cotler, Karen F, Chaisson, Lelia H, Jimenez, Antonio, Guerrero, Stephanie, Fortson, Neisha, Tai, Rex. (2022). 1242. Hepatitis C Treatment as a Complement to Syringe Service Programs: Pilot Progress and Pathways Forward. Open Forum Infectious Diseases, 9, (Supplement_2), ofac492.1073. doi:10.1093/ofid/ofac492.1073.
Januszka, Jenna, Drwiega, Emily N, Drwiega, Emily N, Burgos, Rodrigo M, Michienzi, Sarah M, Smith, Renata, Badowski, Melissa E. (2022). 2060. Evaluation of the real world incidence of integrase inhibitor resistance since adoption as guideline preferred therapy. Open Forum Infectious Diseases, 9, (Supplement_2), ofac492.1682. doi:10.1093/ofid/ofac492.1682.
Lee, Clara, Sapasap, Jenna, LaRochelle, Joseph, Smith, Renata O, Badowski, Melissa E. (2021). Antiretroviral Therapy in Children and Adolescents: A Look Into Modern Single Tablet Regimens.. The Journal of Pediatric Pharmacology and Therapeutics, 26, (8), 783-794. doi:10.5863/1551-6776-26.8.783.
Badowski, Melissa E, Britt, Nicholas, Huesgen, Emily C, Lewis, Michelle M, Miller, Misty M, Nowak, Kathleen, Sherman, Elizabeth, Smith, Renata O. (2021). Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 41, (3), 299-314. doi:10.1002/phar.2499.
Brizzi, Marisa B, Burgos, Rodrigo M, Chiampas, Thomas D, Michienzi, Sarah M, Smith, Renata, Yanful, Paa Kwesi, Badowski, Melissa E. (2020). Impact of Pharmacist-Driven Antiretroviral Stewardship and Transitions of Care Interventions on Persons With Human Immunodeficiency Virus. Open Forum Infectious Diseases, 7, (8), ofaa073. doi:10.1093/ofid/ofaa073.
Brizzi, Marisa B, Burgos, Rodrigo M, Chiampas, Thomas D, Michienzi, Sarah M, Smith, Renata, Badowski, Melissa E. (2019). 1309. Effects of a Pharmacist-Driven Antiretroviral Stewardship and Transitions of Care Service in Persons Living with HIV/AIDS. Open Forum Infectious Diseases, 6, (Supplement_2), s471-s472. doi:10.1093/ofid/ofz360.1172.
Michienzi, Sarah, Burgos, Rodrigo, Smith, Renata, Martin, Michelle. (2018). 2236. Direct-Acting Antivirals: Efficacy in a Real-World, Urban, Undeserved, HIV-HCV Co-Infected Population. Open Forum Infectious Diseases, 5, (suppl_1), s661-s662. doi:10.1093/ofid/ofy210.1889.
Smith, RO, Michienzi, Sarah. (2018). HIV PrEP: Role of the Clinical Pharmacist. HIV Specialist. .
Professional Leadership
Interdisciplinary mentoring, UIHealth, 1/3/2022 - 12/17/2021
AFC Medical Advisory Group Chicago, 1/3/2022 - Present
CRRT COVID Vaccination, Chicago department of public health, 3/1/2021 - 12/31/2021
UI Health World AIDS Day, UIC, 10/2/2020 - 12/6/2019
Elections Society of Infectious Diseases Pharmacists, 10/1/2020 - 10/1/2014
Gender Affirming Care Clinic Development, UI Health, 5/3/2019 - Present
GPPA Honors College Admissions, UIC, 1/5/2018 - 10/4/2019
SIDP Membership Application, SIDP, 10/1/2012 - 5/1/2018
Education
Degrees:
Pharm.D, University of Illinois at Peoria, United States, 1996
Postgraduate Training:
PGY1, UIC, United States, 1997
ID PGY2, UIHealth, United States, 1998